EcoDrugPlus

Phosphodiesterase 3a

Ensembl ID : ENSEEEG00000001482
Gene Symbol: PDE3A
2 Cross references
203 Possible Orthologues:

Phosphodiesterase 3b

Ensembl ID : ENSEEEG00000019709
Gene Symbol: PDE3B
2 Cross references
204 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSEEEG00000005212
Gene Symbol: PDE4A
4 Cross references
187 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSEEEG00000010332
Gene Symbol: PDE4B
4 Cross references
224 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSEEEG00000019836
Gene Symbol: PDE4B
4 Cross references
229 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSEEEG00000022008
Gene Symbol: PDE4D
2 Cross references
144 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSEEEG00000011209
Gene Symbol: PDE4D
2 Cross references
222 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific, B

Ensembl ID : ENSEEEG00000004285
Gene Symbol: PDE5AB
4 Cross references
210 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSEEEG00000010552
Gene Symbol: PDE7A
4 Cross references
215 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSEEEG00000007688
Gene Symbol: PDE7A
4 Cross references
167 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSEEEG00000011536
Gene Symbol: PDE9A
4 Cross references
192 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 5

Ensembl ID : ENSEEEG00000020717
Gene Symbol: PIK3R5
2 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).